Monthly Archives: April 2021

The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study

Posted on by

The Lancet
Apr 03, 2021 Volume 397 Number 10281 p1237-1324, e10
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study
Stephanie J Salyer, et al
Although the first wave of the COVID-19 pandemic progressed more slowly in Africa than the rest of the world, by December, 2020, the second wave appeared to be much more aggressive with many more cases. To date, the pandemic situation in all 55 African Union (AU) Member States has not been comprehensively reviewed. We aimed to evaluate reported COVID-19 epidemiology data to better understand the pandemic’s progression in Africa.

Health data poverty: an assailable barrier to equitable digital health care

Posted on by

Lancet Digital Health
Apr 2021 Volume 3 Number 4 e204-e273
https://www.thelancet.com/journals/landig/issue/current

 

Viewpoint
Health data poverty: an assailable barrier to equitable digital health care
Hussein Ibrahim, Xiaoxuan Liu, Nevine Zariffa, Andrew D Morris, Alastair K Denniston
Summary
Data-driven digital health technologies have the power to transform health care. If these tools could be sustainably delivered at scale, they might have the potential to provide everyone, everywhere, with equitable access to expert-level care, narrowing the global health and wellbeing gap. Conversely, it is highly possible that these transformative technologies could exacerbate existing health-care inequalities instead. In this Viewpoint, we describe the problem of health data poverty: the inability for individuals, groups, or populations to benefit from a discovery or innovation due to a scarcity of data that are adequately representative. We assert that health data poverty is a threat to global health that could prevent the benefits of data-driven digital health technologies from being more widely realised and might even lead to them causing harm. We argue that the time to act is now to avoid creating a digital health divide that exacerbates existing health-care inequalities and to ensure that no one is left behind in the digital era.

Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9–50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study

Posted on by

Lancet Infectious Diseases
Apr 2021 Volume 21 Number 4 p439-578, e67-e109
https://www.thelancet.com/journals/laninf/issue/current

 

Articles
Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9–50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study
Diana Leticia Coronel-MartÍnez, et al.

Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials

Posted on by

Lancet Infectious Diseases
Apr 2021 Volume 21 Number 4 p439-578, e67-e109
https://www.thelancet.com/journals/laninf/issue/current

 

Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials
Carlos A DiazGranados, et al.

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial

Posted on by

Lancet Infectious Diseases
Apr 2021 Volume 21 Number 4 p439-578, e67-e109
https://www.thelancet.com/journals/laninf/issue/current

 

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
Ananda S Bandyopadhyay, et al.
Open Access

The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials

Posted on by

Lancet Infectious Diseases
Apr 2021 Volume 21 Number 4 p439-578, e67-e109
https://www.thelancet.com/journals/laninf/issue/current

 

Personal View
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials
Jerome Amir Singh, Ross E G Upshur
Summary
An efficacious COVID-19 vaccine is currently the world’s leading research priority. Several nations have indicated that if there is a compelling case for use of a vaccine before it is licensed, they would be prepared to authorise its emergency use or conditional approval on public health grounds. As of Dec 1, 2020, several developers of leading COVID-19 candidate vaccines have indicated that they have applied, or intend to apply, for emergency authorisation for their vaccines. Should candidate vaccines attain emergency use designation and be programmatically deployed before their phase 3 trials conclude, such a strategy could have far reaching consequences for COVID-19 vaccine research and the effective control of the COVID-19 pandemic. These issues merit careful consideration.

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

Posted on by

Lancet Public Health
Apr 2021 Volume 6 Number 4 e192-e259
https://www.thelancet.com/journals/lanpub/issue/current

 

Articles
COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics
Michaël Schwarzinger, Verity Watson, Pierre Arwidson, François Alla, Stéphane Luchini

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial

Posted on by

Lancet Respiratory Medicine
Apr 2021 Volume 9 Number 4 p319-434, e30-e46
https://www.thelancet.com/journals/lanres/issue/current

 

Articles
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
Tracey A Day, et al for the TBVPX-203 study team

The TOPMed genomic resource for human health

Posted on by

Nature Reviews Genetics
Volume 22 Issue 4, April 2021
https://www.nature.com/nrg/volumes/22/issues/4

 

In Brief | 02 March 2021
The TOPMed genomic resource for human health
The TOPMed consortium report whole-genome sequencing data from 53,831 ethnically diverse participants. They describe the key features of the genetic variation and produce data resources for future medical research by the wider scientific community.
Darren J. Burgess

COVID-19 vaccines: modes of immune activation and future challenges

Posted on by

Nature Reviews Immunology
Volume 21 Issue 4, April 2021
https://www.nature.com/nri/volumes/21/issues/4

 

Comment | 05 March 2021
COVID-19 vaccines: modes of immune activation and future challenges
This Comment outlines how the recently licensed vaccines for COVID-19 activate innate immune mechanisms to promote immune memory to SARS-CoV-2. The authors also consider future challenges that could limit vaccine efficacy.
John R. Teijaro & Donna L. Farber

Signals of hope: gauging the impact of a rapid national vaccination campaign

Posted on by

Nature Reviews Immunology
Volume 21 Issue 4, April 2021
https://www.nature.com/nri/volumes/21/issues/4

 

Comment | 12 March 2021
Signals of hope: gauging the impact of a rapid national vaccination campaign
Preliminary data from Israel demonstrate real-life effectiveness of their COVID-19 vaccination campaign and provide insights that could inform rollout in other countries.
Smadar Shilo, Hagai Rossman  & Eran Segal

A Half-Century of Progress in Health: The National Academy of Medicine at 50: Emerging Infectious Diseases — Learning from the Past and Looking to the Future

Posted on by

New England Journal of Medicine
April 1, 2021 Vol. 384 No. 13
http://www.nejm.org/toc/nejm/medical-journal

 

Perspective
A Half-Century of Progress in Health: The National Academy of Medicine at 50: Emerging Infectious Diseases — Learning from the Past and Looking to the Future
Christopher Elias, M.D., M.P.H., John N. Nkengasong, Ph.D., and Firdausi Qadri, Ph.D.
Remarkable progress has been made in preventing deaths from infectious diseases. Now, attention could shift to focusing more resources on pandemic preparedness, including detecting and containing emerging zoonotic threats while they are localized and manageable.

Brief Report: Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease

Posted on by

New England Journal of Medicine
April 1, 2021 Vol. 384 No. 13
http://www.nejm.org/toc/nejm/medical-journal

 

Original Articles
Brief Report: Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease
Placide Mbala-Kingebeni, M.D., Ph.D. et al
Summary
During the 2018–2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus–based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) (Merck). His treatment included an Ebola virus (EBOV)–specific monoclonal antibody (mAb114), and he recovered within 14 days. However, 6 months later, he presented again with severe EVD-like illness and EBOV viremia, and he died. We initiated epidemiologic and genomic investigations that showed that the patient had had a relapse of acute EVD that led to a transmission chain resulting in 91 cases across six health zones over 4 months. (Funded by the Bill and Melinda Gates Foundation and others.)

Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country

Posted on by

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 3 Apr 2021)

 

Research Article
Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country
Yi-Hua Pan, Mei-Ying Liao, Yu-Wen Chien, Tzong-Shiann Ho, Hui-Ying Ko, Chin-Rur Yang, Shu-Fen Chang, Chia-Yi Yu, Shu-Yu Lin, Pin-Wei Shih, Pei-Yun Shu, Day-Yu Chao, Chao-Ying Pan, Hong-Ming Chen, Guey-Chuen Perng, Chia-Chi Ku, Chwan-Chuen King
| published 01 Apr 2021 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0009312

Rapidly modifiable factors associated with full vaccination status among children in Niamey, Niger: A cross-sectional, random cluster household survey

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 3 Apr 2021]

 

Rapidly modifiable factors associated with full vaccination status among children in Niamey, Niger: A cross-sectional, random cluster household survey
Mika Kondo Kunieda, Mahamane Laouali Manzo, Akira Shibanuma, Masamine Jimba
Research Article | published 31 Mar 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0249026

Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China

Posted on by

PNAS – Proceedings of the National Academy of Sciences of the United States of America
March 30, 2021; vol. 118 no. 13
https://www.pnas.org/content/118/13

 

Economic Sciences
Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China
Ember (Yiwei) Lu, Hui-Han Chen, Hongqing Zhao, and Sachiko Ozawa
PNAS March 30, 2021 118 (13) e2004933118; https://doi.org/10.1073/pnas.2004933118

Looking to the empirical literature on the potential for financial incentives to enhance adherence with COVID-19 vaccination

Posted on by

Preventive Medicine
Volume 145 April 2021
https://www.sciencedirect.com/journal/preventive-medicine/vol/145/suppl/C

 

Discussion Full text access
Looking to the empirical literature on the potential for financial incentives to enhance adherence with COVID-19 vaccination
Stephen T. Higgins, Elias M. Klemperer, Sulamunn R.M. Coleman
Article 106421

Expectant parents’ vaccine decisions influenced by the 2018 Chinese vaccine crisis: A cross-sectional study

Posted on by

Preventive Medicine
Volume 145 April 2021
https://www.sciencedirect.com/journal/preventive-medicine/vol/145/suppl/C

 

Research article Abstract only
Expectant parents’ vaccine decisions influenced by the 2018 Chinese vaccine crisis: A cross-sectional study
Xiaomin Wang, Leesa Lin, Jiayao Xu, Weiyi Wang, Xudong Zhou
Article 106423

The Intersection of Problems, Policy, and Politics: The Adoption of an HPV Vaccine School-Entry Requirement in Puerto Rico

Posted on by

Qualitative Health Research
Volume 31 Issue 5, April 2021
http://qhr.sagepub.com/content/current

 

Research Articles
The Intersection of Problems, Policy, and Politics: The Adoption of an HPV Vaccine School-Entry Requirement in Puerto Rico
Coralia Vázquez-Otero, Ellen M. Daley, Cheryl A. Vamos, Nancy Romero-Daza, Jason Beckstead, Dinorah Martinez Tyson
First Published March 18, 2021; pp. 859–870

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Posted on by

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 3 Apr 2021]

 

https://stm.sciencemag.org/
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Authors: Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt, Isabelle Boutron, Tammy C. Hoffmann, Cynthia D. Mulrow, Larissa Shamseer, Jennifer M. Tetzlaff, Elie A. Akl, Sue E. Brennan, Roger Chou, Julie Glanville, Jeremy M. Grimshaw, Asbjørn Hróbjartsson, Manoj M. Lalu, Tianjing Li…
Citation: Systematic Reviews 2021 10:89
Content type: Research
Published on: 29 March 2021

Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers’ perspective

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 3 Apr 2021)

 

Research article Abstract only
Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers’ perspective
Frederik Verelst, Philippe Beutels, Niel Hens, Lander Willem
Pages 2005-2015

Awareness, Attitudes and Clinical Practices Regarding Human Papillomavirus Vaccination among General Practitioners and Pediatricians in Switzerland

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 3 Apr 2021)

 

Open Access Article
Awareness, Attitudes and Clinical Practices Regarding Human Papillomavirus Vaccination among General Practitioners and Pediatricians in Switzerland
by Levy Jäger, Oliver Senn, Thomas Rosemann and Andreas Plate
Vaccines 2021, 9(4), 332; https://doi.org/10.3390/vaccines9040332 – 01 Apr 2021
Abstract
In Switzerland, the human papillomavirus vaccination (HPVv) coverage rate lies below a desirable threshold. General practitioners (GPs) and pediatricians have been recognized as important providers of the HPVv, but there is little known about their self-attributed role and its relationship with their actual […

COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 3 Apr 2021)

 

Open Access Article
COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study
by Dalia Almaghaslah, Abdulrhman Alsayari, Geetha Kandasamy and Rajalakshimi Vasudevan
Vaccines 2021, 9(4), 330; https://doi.org/10.3390/vaccines9040330 – 01 Apr 2021
Abstract
Ending the COVID-19 pandemic requires achieving herd immunity, either by previous infection or by vaccination. However, concerns about the COVID-19 vaccine are growing around the globe. The current study was conducted to investigate young the adult population’s hesitancy towards the vaccine. The study [

The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 3 Apr 2021)

 

Open Access Review
The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines
by Tasnim Hasan, Justin Beardsley, Ben J. Marais, Thu Anh Nguyen and Greg J. Fox
Vaccines 2021, 9(4), 326; https://doi.org/10.3390/vaccines9040326 – 01 Apr 2021
Abstract
The global drive to vaccinate against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) began in December 2020 with countries in Europe, Middle East, and North America leading the roll out of a mass-vaccination program. This systematic review synthesised all available English-language guidelines and research regarding […]

Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 3 Apr 2021)

 

Open Access Review
Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing
by William Douglas Evans and Jeff French
Vaccines 2021, 9(4), 319; https://doi.org/10.3390/vaccines9040319 – 01 Apr 2021
Abstract
The COVID-19 pandemic has led to millions of deaths and tested the capabilities of the medical and public health systems worldwide. Over the next two years as more approved vaccines are made available and supply meets or exceeds demand, medical and public health […]

Media/Policy Watch

Posted on by

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
The sheer volume of vaccine and pandemic-related coverage is extraordinary. We will strive to present the most substantive analysis and commentary we encounter.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 3 Apr 2021
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 3 Apr 2021
[No new, unique, relevant content]

 

The Economist
http://www.economist.com/
Accessed 3 Apr 2021
Briefing
Why the EU’s covid-19 vaccination programme went wrong
The commission should have done much better

 

Financial Times
https://www.ft.com/
Accessed 3 Apr 2021
The Big Read
Brazil’s coronavirus nightmare: ‘Bolsonaro is more isolated than ever’
April 3, 2021
Top of Form
Bottom of Form

Interview
Lunch with the FT
UK vaccine supremo Kate Bingham: ‘The bickering needs to stop’
…“You need to be sure that the vaccines are safe and that if you take the vaccine, you will get protected….
April 3, 2021

Bottom of Form

Coronavirus latest: Pfizer trial points to vaccine effectiveness against South Africa variant
Italy to make vaccines mandatory for healthcare workers
April 1, 2021

 

Forbes
http://www.forbes.com/
Accessed 3 Apr 2021
Apr 2, 2021
Florida Gov. Ron DeSantis Bans Vaccine Passports Amid GOP Pushback
Some businesses are already requiring vaccine proof.
By Nicholas Reimann Forbes Staff

Apr 1, 2021
WHO Calls Out Europe For ‘Unacceptably Slow’ Vaccine Rollout, Warns It Will Prolong Pandemic
The global body noted that more than 1.6 million people have contracted Covid-19 in Europe in the past week and the numbers are continuing to rise.
By Siladitya Ray Forbes Staff

Mar 31, 2021
How Counterfeit Covid-19 Vaccines And Vaccination Cards Endanger Us All
As much as 10% of medicines are thought to be counterfeit. The growing trade in falsified and substandard drugs is worsening and endangers us in surprising ways.
By Judy Stone Senior Contributor

Mar 31, 2021
‘World’s First’ Animal Covid-19 Vaccine Registered In Russia – Here’s What That Means
Millions of mink were culled due to widespread outbreaks of Covid-19, sparking fears for the future of the fur industry.
By Robert Hart Forbes Staff

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 3 Apr 2021
[No new, unique, relevant content]

 

Foreign Policy
http://foreignpolicy.com/
Accessed 3 Apr 2021
Latin America’s COVID-19 Fiasco Is Also a Crisis of Regional Integration
A spat at Mercosur’s 30th birthday marked a low point for regional cooperation.
By Catherine Osborn | April 2, 2021, 8:00 AM

 

Russia and China Are Exploiting Europe’s Vaccine Shortfalls
Slovakia’s prime minister has resigned over a secret delivery of Moscow’s Sputnik V as Brussels struggles to keep the EU united.
By Tim Gosling | March 31, 2021, 10:30 AM

 

New Yorker
http://www.newyorker.com/
Accessed 3 Apr 2021
[No new, unique, relevant content]

 

New York Times
http://www.nytimes.com/
Accessed 3 Apr 2021
World
Kenya, expressing concern about counterfeit vaccines, blocks private imports of doses.
The move comes after private health facilities started administering Russia’s Sputnik V vaccine, charging up to $70 for a shot.
By Abdi Latif Dahir

Americas
Argentina’s President Tests Positive for Coronavirus Despite Vaccination
Alberto Fernández, who received early results on his 62nd birthday, was confirmed to have the virus in a later PCR test. His symptoms were said to be mild.
By Daniel Politi

U.S.
Florida’s governor bans agencies and businesses from requiring ‘vaccine passports.’
The Biden administration has made clear that it will neither issue nor require so-called vaccine passports, but Republicans have seized on the issue as an example of government overreach.
By Patricia Mazzei, Sheryl Gay Stolberg, Eileen Sullivan and Isabella Grullón Paz

Health
Can Vaccinated People Spread the Virus? We Don’t Know, Scientists Say.
Researchers pushed back after the C.D.C. director asserted that vaccinated people “do not carry the virus.”
By Apoorva Mandavilli
PRINT EDITION April 3, 2021

 

Washington Post
https://www.washingtonpost.com/
Accessed 3 Apr 2021
Vaccine passport efforts draw opposition from GOP lawmakers
Apr 3, 2021

Africa CDC says India vaccine woes could be ‘catastrophic’
Apr 1, 2021

Think Tanks et al

Posted on by

Think Tanks et al

Brookings
http://www.brookings.edu/
Accessed 3 Apr 2021
Future Development
For greater vaccine equity, first fix these misconceptions
Philip Schellekens
Friday, April 2, 2021

Coronavirus (COVID-19)
“Vaccine Passport” certification — Policy and ethical considerations
Mark Hall and David Studdert
Thursday, April 1, 2021
 
 
Center for Global Development [to 3 Apr 2021]
http://www.cgdev.org/page/press-center
Publication
April 2, 2021
A Global Pandemic Needs A Global Response: US Contributions to COVID Relief
The American Rescue Plan—the massive COVID-19 relief package recently signed into law—has featured in plenty of headlines. While the vast majority of the nearly $1.9 trillion package is allocated to domestic relief and response, the legislation provides nearly $11 billion in supplemental international affairs spending. We dug in to see how this new injection of funding compares to emergency foreign assistance provided under previous pandemic-related legislation and share some areas we hope to see USAID and the State Department prioritize as they work to put the new money to good use.
Erin Collinson and Jocilyn Estes

March 30, 2021
The Indirect Health Effects of COVID-19: Emerging Findings from Kenya, the Philippines, South Africa, and Uganda
Much of the initial COVID response focused on limiting cases and deaths, without sufficient attention to the broader indirect impacts. A new CGD series investigates.
Carleigh Krubiner et al.
 
 
Chatham House [to 3 Apr 2021]
https://www.chathamhouse.org/
Accessed 3 Apr 2021
Culture notes: Jabs that started a vaccine fight
Catherine Fieschi on how the world fell out trying to counter a pandemic
The World Today
2 April 2021

 
 
CSIS
https://www.csis.org/
Accessed 3 Apr 2021
Upcoming Event
Trusting a Covid-19 Vaccine: What’s Next?
April 9, 2021

Transcript
Africa’s Global Reset: Foreign Relations in a Post-Pandemic Era
March 31, 2021

 
 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 3 Apr 2021
March 30, 2021 News Release
Vaccine Monitor: 6 in 10 Adults Have Either Gotten a COVID-19 Vaccine or Want To “as Soon as Possible;” “Wait and See” Group Continues To Shrink
Among Those Who Have Not Been Vaccinated, 3 in 10 Are Unsure if They are Eligible Yet; Hispanic Adults and People with Low Incomes More Likely to Be Unsure The latest KFF COVID-19 Vaccine Monitor report finds enthusiasm for getting a COVID-19 vaccine continuing to grow, with roughly 6 in…

March 29, 2021 News Release
New Analysis Indicates U.S. County Vaccination Rates Do Not Correspond to COVID-19 Impact Thus Far
An analysis of Centers for Disease Control and Prevention (CDC) COVID-19 vaccination data from 72% of all counties in the U.S. shows that counties classified as having “low” COVID-19 community transmission (cases and positive tests) levels have an average vaccination rate greater than the rate in counties with “high” community…
 
 
World Economic Forum [to 3 Apr 2021]
https://agenda.weforum.org/news/
Media
Accessed 3 Apr 2021
[No new digest content identified]